Evonik Industries (XTRA:EVK) Draws BASF Bid Interest, Is The Stock Fully Priced?

Evonik Industries (XTRA:EVK) is back in focus after reports that BASF SE is exploring a potential acquisition, raising fresh questions about portfolio overlap, pricing power and how a combined supplier might reshape ingredient markets.

For context, Evonik Industries has seen strong momentum build ahead of the BASF headlines, with a 90-day share price return of 21.06% and a year-to-date share price gain of 45.53%. The 1-year total shareholder return of 40.25% comes after a slightly negative 5-year total shareholder return of 3.42%, suggesting recent enthusiasm is concentrated in the short to medium term as investors reassess both opportunity and risk around the business.

Scan other potential beneficiaries or rivals to an Evonik Industries and BASF tie-up by reviewing our hand picked list of solid balance sheet and fundamentals (201 results) in the chemicals and industrials space.

Evonik Industries now trades on a very different footing after the bid speculation and recent gains. Does the current valuation still offer an attractive balance between potential upside and deal risks for new buyers?

Most Popular Narrative: 6% Overvalued

Evonik Industries closed at €19.37 against a widely followed fair value estimate of €18.28, so the current price sits a little above that narrative anchor while investors debate how much future execution is already in the quote.

Ongoing portfolio shift towards high-margin specialty chemicals and away from commoditized businesses is aligned with strict regulatory trends and customer demands for eco-friendly, high-value additives, which is viewed as supporting both top-line growth and structural margin uplift over the long term.

See why 29 investors see Evonik Industries as 6% overvalued .

Result: Fair Value of €18.28 (OVERVALUED)

Still, the Evonik Industries story can unwind quickly if weak demand in construction and autos persists, or if commodity exposures drag longer than analysts assume.

Find out about the key risks to this Evonik Industries narrative .

Another Take On Evonik Industries Valuation

Analyst targets suggest Evonik Industries is modestly overvalued around €19.37 versus a fair value view of €18.28. The SWS DCF model points in a very different direction, with an estimated future cash flow value of €71.10, implying the shares trade well below that figure. Which signal matters more to you?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Evonik Industries for example ). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 182 high quality undervalued stocks . If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.